Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. - Wikidata - wikimedia - TriplyDB

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

http://www.wikidata.org/entity/Q34625006

about

Cloning and expression of the tumor-associated antigen L6 A humanized antibody that binds to the interleukin 2 receptor Antibody-drug conjugates as novel anti-cancer chemotherapeutics A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments.Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity Secretion of functional antibody and Fab fragment from yeast cells Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting.Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library.Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Immunoglobulin V gene replacement is caused by the intramolecular DNA deletion mechanism TM4SF1: a new vascular therapeutic target in cancer Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting.Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys.m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.Heavy chain variable (VH) region diversity generated by VH gene replacement in the progeny of a single precursor cell transformed with a temperature-sensitive mutant of Abelson murine leukemia virus Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.Secretion of a single-gene-encoded immunoglobulin from myeloma cells NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics.Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product.Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.Genetically engineered antibody molecules: new tools for cancer therapy.Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.The intron requirement for immunoglobulin gene expression is dependent upon the promoter.Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice.Increased antibody affinity and specificity by codon-based mutagenesis.Humanized antibodies: enhancing therapeutic utility through antibody engineering.Monoclonal antibody-conjugated immunotherapy of cancer.Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment.The therapeutic value of monoclonal antibodies directed against immunogenic tumor glycoproteins.Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.Genetically engineered (chimeric) antibodies.Neuro-ophthalmic side effects of molecularly targeted cancer drugs.Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein.Preoperative clinical radioimmunodetection of pancreatic cancer by 111 In-labeled chimeric monoclonal antibody Nd2.Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancer.A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging.

P2860

Q24562028-197B14AD-8941-4CBD-A870-E7779F258BF1 Q24600912-A9F6AC37-FA67-424A-BA07-AA58895E4AC0 Q26800175-000108FC-4715-4A2F-9141-6ACC764F38D8 Q30657795-37916657-FE6D-404F-BD37-B67EF29ECA3F Q33586088-2740E2E1-C604-4B63-A403-263A828BC73F Q33672201-52552A82-5A44-411F-A6B0-8767A05AA714 Q33685694-917457AA-9444-46CA-A2BD-2BAACDF322CA Q33850314-1E2770C6-7801-46A2-9BBA-2BBBA1BED587 Q33867651-C887C012-1A30-4D86-8D29-90A50568037F Q33937403-78151555-EA3B-4349-8862-0E8AE2914370 Q34254434-47C8504C-BED6-413A-85EA-67779A023FB6 Q34317211-44C682C0-8135-46AF-A0F6-EB9EFE34FB1A Q34979203-1C4DAE9F-6FB6-4F29-B194-0B9782A88F02 Q36079704-8159A281-101D-418A-ACC1-DDAAC1F70435 Q36108564-42F7471B-DCE3-4F3B-921A-CAADDD5C2A28 Q36231866-BDB6E762-AC6C-4B1B-83F8-425C0D3DD17B Q36350233-84A74970-9472-42AF-AB2F-E6357590B166 Q36503787-1BC8BBE3-4265-4BFB-8E78-0FCAE9053C48 Q36613467-D5563EB6-06FE-4814-A561-B6D3AA90E449 Q38311690-2810ADF9-4350-4643-AA76-131F30EBAFA3 Q38620978-D24C938E-A4DA-4EB5-9A2D-E2A9FB7C57EC Q39644773-B94D62FF-85A9-4196-BCD2-A7262A068F11 Q40407910-13BF7467-197C-4FA7-9EAF-789833D2AFB8 Q40553974-E4FF873E-0F1E-4E5E-AE47-481C3E7FF366 Q40756128-6CB1BE22-6B98-435D-95DE-0E38027272E0 Q40840143-7256521E-ED6E-4BFA-BFB9-83E672B6D0C7 Q40840186-AC539EFA-B9CE-46F8-B51D-E685C40C265F Q41455943-DEA9D98A-1AE2-43EB-BD94-AD83F6B67122 Q41870446-35491CCA-94FB-491F-9AC8-254FA42D58BD Q42380349-F78171EB-9ABA-4172-8CD6-2A7B31B1A7FB Q42940097-4A2178A5-3E4F-4F9C-9512-B6B7EEC59908 Q43833991-D08DE2A8-1EFB-4224-B069-389760BACC1E Q44793364-FA8A7E58-26E7-4669-BE62-0A7C0743333D Q47625145-8CBC7541-F522-4FC0-966D-BE018C9B09C2 Q54269812-FF4733B3-2FD7-4BDA-9B4C-9B5DDE081CA6 Q54915559-1BE42542-66E3-47F2-8AD5-9EE29E77BDC7 Q55035074-D7E7A77E-279B-4B40-81DD-DA9B7D140441 Q55357190-6DB0140C-8A8B-4D9C-9FAD-52406DB5A7E6

P2860

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

http://www.wikidata.org/entity/Q34625006

description

1987 nî lūn-bûn

@nan

1987 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@ast

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@en

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@nl

type

label

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@ast

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@en

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@nl

prefLabel

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@ast

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@en

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@nl

P1433

Q34625006-1430BC48-614C-4B78-94A0-B65415C2B550

P1476

Q34625006-53619470-FCD8-47AB-BED7-2C5C56740BCF

P2093

Q34625006-17569E29-49AA-4BA7-BF99-32E199275F6C

Q34625006-1AA1A40F-D610-4086-B625-DEA746BAE799

Q34625006-31256DB4-C3B3-4DCF-AFB4-1B36D2431352

Q34625006-60B57456-0CF5-491D-AF1D-F208F17FD63F

Q34625006-65A19216-24FB-4584-BAF5-74F1C4F5277B

Q34625006-D4029897-E3FC-4748-BF9E-A038EB2338F4

P2860

Q34625006-0318D1A8-BEE2-412E-BF9E-EDE25E0BD5E8

Q34625006-0CC465F9-F6B4-45F8-A0FC-DEB4CDBCA874

Q34625006-25D7C25C-B785-4FF5-B018-DF375A085C43

Q34625006-355756E5-2AE2-41D7-90EB-13DB391BBBA7

Q34625006-385A67F3-620E-487C-952A-65242FC430A9

Q34625006-419743DF-E3C5-4BD5-B5A8-9B0E7C50FDDA

Q34625006-52DDDE65-AF06-4A93-82C1-10BC7B76CDB8

Q34625006-63DED0CE-4BFD-425C-8771-562DECC3C154

Q34625006-766B7EC1-30E8-4E2A-9786-837965477D73

Q34625006-8D6FEF20-77F7-4533-9E0B-AF69B4F25FD4

P304

Q34625006-BF09875B-5E10-4CBB-9874-2A3E8C410DAE

P31

Q34625006-9874EBF0-39FD-4557-AA5F-A57E3A6D4975

P356

Q34625006-FFFEC9EC-9181-49AB-9DDE-2FBA9D041739

P407

Q34625006-DBE553CC-97E5-46F4-82FD-E4F56CB444BB

P433

Q34625006-4563498E-5059-4947-9C61-4ED989B63BE2

P478

Q34625006-F9C97F8C-F84C-4C27-97BA-09E41AD6BE2A

P577

Q34625006-8F5D5CE7-E474-4530-BF0B-DA7CFDBEC647

P5875

Q34625006-F6CCBBDB-AD17-4CF9-BA12-D99BF466902D

P698

Q34625006-2BA7AA08-BEA6-4CE9-AE0D-AEF0F4995C56

P921

Q34625006-280F0589-FB18-4E79-9C00-10F4511FD19B

P932

Q34625006-D94C101C-4A74-4135-A904-A41252B5EC59

P356

PNAS.84.10.3439

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

@en

P2093

Chang CP

http://www.w3.org/2001/XMLSchema#string

Hellström I

http://www.w3.org/2001/XMLSchema#string

Hellström KE

http://www.w3.org/2001/XMLSchema#string

Liu AY

http://www.w3.org/2001/XMLSchema#string

Murray ED Jr

http://www.w3.org/2001/XMLSchema#string

Robinson RR

http://www.w3.org/2001/XMLSchema#string

P2860

A simple and very efficient method for generating cDNA libraries

New M13 vectors for cloning

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter

A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Extracellular nucleases of pseudomonas BAL 31. III. Use of the double-strand deoxyriboexonuclease activity as the basis of a convenient method for the mapping of fragments of DNA produced by cleavage with restriction enzymes.

Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells.

Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

P304

3439-3443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.84.10.3439

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

1987-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20049255

http://www.w3.org/2001/XMLSchema#string

P698

3106970

http://www.w3.org/2001/XMLSchema#string

P921

P932

304886

http://www.w3.org/2001/XMLSchema#string